Duke University Patent Portfolio Statistics

tip_user1

Duke University

Profile Summary

This article summarizes the perfomance of the assignee in the recent years. The overall statistics for this portfolio help to analyze the areas where the assignee is performing well. The filing trend, perfomance across the tech centers and the perfomance of the recent applications has been mentioned below. All the stats are calculated based on the perfomance in USPTO.

How does the overall patent portfolio of Duke University look like?

Assignee Art Units
Total Applications: 2,282 1,950,494
Granted Patents: 1,228 1,078,785
Grant Index 68.83% ↓ 69.9%
Abandoned/Rejected Applications: 556 (31.17%) 464,551 (30.1%)
In-Process Applications: 494 407,158
Average Grant Time: 3.21 Years ↑ 2.82 Years
Average Office Actions: 1.92 ↑ 1.67

Which Technology Area Duke University is filing most patents in? (Last 10 years)

Art Unit Definition Total Applications
1648 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 124
Opap Parked GAU 95
1634 Molecular Biology, Bioinformatics, Nucleic Acids, Recombinant DNA and RNA, Gene Regulation, Nucleic Acid Amplification, Animals and Plants, Combinatorial/ Computational Chemistry 65
1652 Fermentation, Microbiology, Isolated and Recombinant Proteins/Enzymes 60
1644 Immunology, Receptor/Ligands, Cytokines Recombinant Hormones, and Molecular Biology 55

How many patents are Duke University filing every year?

Year Total Applications Predicted
2022 1* 271
2021 64* 256
2020 126 268
2019 142 142
2018 154 –
2017 138 –
2016 114 –
2015 89 –
2014 115 –
2013 88 –

*The drop in the number of applications filed in last two years compared to previous years is because applications can take up to 18 months to get published

Recently filed patent applications of Duke University in USPTO?

Publication number: US20220178954A1
Application number: 17/437,122

Abstract:
Described herein are methods for stratifying Alzheimer's disease among male and female subjects by analyzing biomarker metabolites. In one aspect, the biomarker metabolite comprises one or more of PC ae C44:4, PC ac C44:5, or PA ae C44:6; or PC ac C44:4, PC ac C44:5, PC aa C32:1, PC aa C32:0, or PC ae C42:4.

Publication date: 2022-06-09
Applicant: Duke University
Inventors: F Kaddurah-Daouk Rima

Publication number: None
Application number: 17/630,659

Abstract:
–

Publication date: –
Applicant: Duke University
Inventors: Chongsathidkiet Pakawat

Publication number: None
Application number: 17/630,667

Abstract:
–

Publication date: –
Applicant: Duke University
Inventors: Alem Kahsai

How are Duke University’s applications performing in USPTO?

Application Number Title Status Art Unit Examiner
17/437,122 Stratification By Sex And Apoe Genotype Identifies Metabolic Heterogeneity In Alzheimers Disease Docketed New Case – Ready for Examination OPAP Central, Docket
17/630,659 Compositions And Methods For The Treatment Of Intracranial Diseases Application Undergoing Preexam Processing 1646 –
17/630,667 Beta-Arrestin-Modulating Compounds And Methods Of Using Same Application Undergoing Preexam Processing – –
17/279,386 Methods And Compositions To Treat And Prevent Infection Docketed New Case – Ready for Examination OPAP Central, Docket
17/538,770 Phosphor-Containing Drug Activator, Suspension Thereof, System Containing The Suspension, And Methods For Use Docketed New Case – Ready for Examination OPAP Central, Docket